BRIEF published on 02/06/2026 at 07:35, 2 months 26 days ago Sensorion to Participate in ARO 49th Annual Midwinter Meeting Biotechnology Gene Therapy Sensorion Hearing Loss ARO Meeting
PRESS RELEASE published on 02/06/2026 at 07:30, 2 months 26 days ago Informations privilégiées / Autres communiqués Sensorion participe à la 49ème rencontre annuelle de l’ARO pour présenter sa nouvelle thérapie génique SENS-601 pour la surdité autosomique récessive non syndromique 1A Thérapie Génique Sensorion Perte Auditive Surdité ARO
PRESS RELEASE published on 02/06/2026 at 07:30, 2 months 26 days ago Inside Information / Other news releases Sensorion to present SENS-601 gene therapy at ARO 49th Annual Midwinter Meeting in Puerto Rico Gene Therapy Sensorion Hearing Loss SENS-601 ARO 49th Annual Midwinter Meeting
BRIEF published on 01/28/2026 at 07:48, 3 months 7 days ago Sensorion Secures €60 Million Financing to Advance Hearing Loss Therapies Gene Therapy Biotech Financing Sensorion Hearing Loss Sanofi Investment
BRIEF published on 01/28/2026 at 07:48, 3 months 7 days ago Sensorion obtient un financement de 60 millions d'euros pour faire progresser les thérapies contre la perte auditive Thérapie Génique Sensorion Perte Auditive Financement Des Biotechnologies Investissements Sanofi
PRESS RELEASE published on 01/28/2026 at 07:43, 3 months 7 days ago Informations privilégiées / Autres communiqués Sensorion annonce un financement de 60 millions d’euros avec Sanofi et d'autres investisseurs pour développer ses thérapies géniques. Trésorerie prévue jusqu'à mi-2027 Financement Trésorerie Thérapie Génique Sanofi Sensorion
PRESS RELEASE published on 01/28/2026 at 07:43, 3 months 7 days ago Inside Information / Other news releases Sensorion announces €60 million financing with a €20M strategic investment from Sanofi and support from global healthcare specialists to advance genetic medicine pipeline. Cash runway extended until H1 2027 Financing Sanofi Sensorion Genetic Medicine Healthcare Specialists
BRIEF published on 12/19/2025 at 07:35, 4 months 16 days ago Sensorion to Present at J.P. Morgan Healthcare Conference Biotechnology Gene Therapy J.P. Morgan Hearing Loss SENS-401
BRIEF published on 12/19/2025 at 07:35, 4 months 16 days ago Sensorion présentera ses services lors de la conférence JP Morgan Healthcare. Biotechnologie Thérapie Génique JP Morgan Perte Auditive SENS-401
PRESS RELEASE published on 12/19/2025 at 07:30, 4 months 16 days ago Informations privilégiées / Autres communiqués Sensorion annonce sa participation à la 44ème conférence annuelle J.P. Morgan Healthcare Conference à San Francisco du 12 au 15 janvier 2026 pour présenter ses avancées en thérapies auditives Biotechnologie Conference J.P. Morgan Sensorion Thérapies Auditives
Published on 05/04/2026 at 16:45, 3 hours 4 minutes ago Inventus Announces Engagement of Red Cloud Securities
Published on 05/04/2026 at 16:27, 3 hours 22 minutes ago Avenir Minerals to Acquire Fox River Resources in All-Cash Transaction for Approximately C$94.3 Million
Published on 05/04/2026 at 15:30, 4 hours 19 minutes ago Silver Spruce Resources Announces Resumption of Exploration at its Melchett Lake Au-Ag-Zn-Pb-Cu Volcanogenic Massive Sulphide Project, Nakina, Ontario
Published on 05/04/2026 at 15:00, 4 hours 49 minutes ago Shelfie Signs Definitive Agreement to Acquire Majority Interest in Israeli Based Aspect Information Systems Ltd.
Published on 05/04/2026 at 14:46, 5 hours 3 minutes ago Worksport (NASDAQ:WKSP) Invited to Present at D. Boral 2026 Global Conference
Published on 05/04/2026 at 19:30, 19 minutes ago Shareholders approve all proposals – Dr Annelise Lüscher Hämmerli and Urs Simeon elected to the Board of Directors
Published on 05/04/2026 at 19:00, 49 minutes ago PATRIMOINE ET COMMERCE: Déclaration des transactions sur actions propres (Hors contrat de liquidité) réalisées du 27 AVRIL 2026 au 01 MAI 2026
Published on 05/04/2026 at 19:00, 49 minutes ago L’Assemblée générale 2026 approuve toutes les propositions du Conseil d’administration
Published on 05/04/2026 at 19:00, 49 minutes ago Shareholders approve all Board proposals at Annual General Meeting
Published on 05/04/2026 at 18:00, 1 hour 49 minutes ago PURE Swiss Opportunity REF (PSO) Key details of the capital increase in May 2026
Published on 05/04/2026 at 19:05, 44 minutes ago CP -Mise en œuvre d’un contrat de liquidité avec INVEST SECURITIES
Published on 05/04/2026 at 18:19, 1 hour 29 minutes ago Covivio Hotels - Informations relatives au nombre total de droits de vote et d’actions composant le capital social
Published on 05/04/2026 at 17:59, 1 hour 49 minutes ago Saint-Gobain has signed an agreement for the sale of its distribution business in Brazil
Published on 05/04/2026 at 17:59, 1 hour 49 minutes ago Saint-Gobain signe un accord de cession de son activité de distribution au Brésil
